# OnCo record wtx-330 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/wtx-330/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "wtx-330" ;
  schema:name "WTX-330"@en ;
  schema:description "WTX-330 is an experimental conditionally activated cytokine pro-drug from Werewolf Therapeutics, in phase 1 trials for advanced or metastatic solid tumours and non-Hodgkin lymphoma; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/wtx-330/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://werewolftx.com/our-pipeline/>, <https://werewolftx.com/our-pipeline/>, <https://www.sec.gov/Archives/edgar/data/1785530/000114036126040784/ny20081588x2_s4a.htm>, <https://clinicaltrials.gov/search?intr=WTX-330> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Conditionally activated cytokine pro-drug (INDUKINE molecule)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:companies <https://onco.cc/companies/werewolf-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct05678998/>, <https://onco.cc/trials/nct06939283/> .